News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • IG Metall called a 24-hour strike Monday involving 23,000 workers at 19 northern German firms.
  • Affected companies include Mercedes-Benz, Meyer Werft and Siemens Gamesa, hitting automakers, shipyards and wind supply chains.
  • Union demands a 5% wage increase or binding investment and job commitments from firms seeking exceptions.
  • Employers proposed delaying permanent pay gains 20 months and a 1.3% raise effective July 2028.
  • The strike raises near-term disruption risk for German industrial output and supply chains.
  • COP31 negotiators released a revised text narrowing language on fossil fuels as delegations race toward approval.

Latest Articles

Ernexa Therapeutics Receives Independent Validation of ERNA-101 with Complete Tumor Clearance and Durable Survival in Ovarian Cancer Models Ahead of Planned Clinical Entry

Ernexa Therapeutics Receives Independent Validation of ERNA-101 with Complete Tumor Clearance and Durable Survival in Ovarian Cancer Models Ahead of Planned Clinical Entry

Ernexa Therapeutics announced independent validation of its lead cell therapy candidate ERNA-101 in combination with anti-PD-1 treatment, achieving complete tumor clearance and long-term survival in 67% of treated animals in ovarian cancer models. No complete responses were observed in monotherapy or control groups. This robust third-party study en…

Buffett Says Ending Donations to Gates Foundation Was a Foreseeable Move

Buffett Says Ending Donations to Gates Foundation Was a Foreseeable Move

Warren Buffett said he informed Bill Gates that he would stop directing Berkshire Hathaway stock gifts to the Gates Foundation, a decision he described as unsurprising after reviewing materials related to Gates' interactions with Jeffrey Epstein. Instead, Buffett will allocate nearly $6 billion in Berkshire shares to four family foundations adminis…

Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026

Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026

Profound Medical Corp. announced its advanced MRI-guided, AI-powered, robotically-driven TULSA Procedure for incisionless prostate ablation will be featured prominently at the Society of Robotic Surgery Annual Meeting (SRS2026). The company will participate in multiple presentations, including clinical outcomes and safety data, as well as an invest…

Burry Rejects Initial $53 Billion PayPal Offer, Says $60.50 Is 'Too Low'

Burry Rejects Initial $53 Billion PayPal Offer, Says $60.50 Is 'Too Low'

Stripe and Advent International have reportedly proposed a $53 billion takeover of PayPal at $60.50 per share, a 28% premium to the most recent close. Michael Burry, who holds PayPal as a top deep-value position, publicly rejected the offer as too low, citing his intrinsic value metrics and arguing a realistic winning bid would be closer to $100 pe…

Kratos: Focus on Backlog and Balance Sheet, Not the Intraday Noise

Kratos: Focus on Backlog and Balance Sheet, Not the Intraday Noise

Kratos (KTOS) trades near $51 after a pullback from its 52-week high. The headline price swings mask a healthier setup: strong funded backlog and liquidity, low debt, and a sizable short base that can compress on positive contract flow. This is a mid-term swing trade that buys into defense tailwinds while respecting execution and cash-flow risk.

Morgan Stanley Posts Higher Q2 Profit on Surge in Deal Activity

Morgan Stanley Posts Higher Q2 Profit on Surge in Deal Activity

Morgan Stanley reported an increase in second-quarter profit, driven largely by elevated mergers and acquisitions activity and stronger investment banking fees. A permissive regulatory backdrop and robust equity markets supported dealmaking, producing record first-half M&A totals and boosting underwriting and advisory revenue for the bank.

Repligen to Report Second Quarter 2026 Financial Results

Repligen to Report Second Quarter 2026 Financial Results

Repligen Corporation, a life sciences company specializing in bioprocessing technologies, announced it will report its second quarter 2026 financial results on July 28, 2026. A conference call and webcast will follow to discuss business updates and financial outcomes for the quarter ending June 30, 2026.

Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers

Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers

Cellectar Biosciences announced the publication of the Phase 1 study results of iopofosine I 131 combined with low-dose dexamethasone in heavily pretreated relapsed/refractory multiple myeloma patients. The study demonstrated a manageable safety profile with predominantly hematologic toxicities and showed encouraging clinical activity, supporting c…

Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

Acumen Pharmaceuticals presented new preclinical data demonstrating that their Enhanced Brain Delivery™ (EBD™) bispecific antibodies achieved markedly improved brain penetration in non-human primates compared to native antibodies. Notably, candidate ACU401 showed up to 40-fold higher frontal cortex exposure with no hematological safety concerns, su…

TappAlpha Expands Growth + Income ETF Platform with TMGN, Bringing Tax-Efficient Income to the Cboe Magnificent 10 Index

TappAlpha Expands Growth + Income ETF Platform with TMGN, Bringing Tax-Efficient Income to the Cboe Magnificent 10 Index

TappAlpha has introduced the TappAlpha Cboe Magnificent 10 Growth & Daily Income ETF (TMGN), an options-overlay ETF providing exposure to the equal-weighted Cboe Magnificent 10 Index. The fund aims to deliver growth and tax-efficient daily income by combining key mega-cap growth stocks with a disciplined options strategy, expanding TappAlpha's Grow…

CAVA Group Shares Tick Higher After Morgan Stanley Raises Rating and Target

CAVA Group Shares Tick Higher After Morgan Stanley Raises Rating and Target

CAVA Group Inc. shares climbed about 3% Wednesday morning following a Morgan Stanley upgrade from equalweight to overweight and an increase in the price target to $90 from $86. The move follows a recent pullback that left the stock closing Tuesday at $69.97. Morgan Stanley analyst Brian Harbour said the upgrade reflects a reassessment after weaknes…

Sify reports Consolidated Financial Results for Q1 FY 2026-27

Sify reports Consolidated Financial Results for Q1 FY 2026-27

Sify Technologies Limited announced its consolidated financial results for Q1 FY 2026-27, reporting a 15% year-over-year revenue increase to INR 12,352 million and a 42% rise in adjusted EBITDA to INR 3,005 million. The company continues to invest heavily in data center capacity, network modernization, and digital platforms to support rising demand…

Morgan Stanley Upgrade Sends CAVA Shares Higher in Pre-Market Trading

Morgan Stanley Upgrade Sends CAVA Shares Higher in Pre-Market Trading

CAVA Group shares rose about 3.6% in pre-market activity after Morgan Stanley upgraded the stock from Equalweight to Overweight and raised its price target to $90 from $86. The upgrade comes while the stock has fallen nearly 20% over the past month and sits notably below its 52-week peak, prompting renewed investor interest amid an otherwise subdue…

Ependion Posts Double-Digit Gains in Orders and Sales for Q2

Ependion Posts Double-Digit Gains in Orders and Sales for Q2

Ependion reported a 24% increase in order intake to 695 million kronor for the second quarter of 2026, alongside a 22% rise in net sales and an improved EBITA and margin. Profit after tax and earnings per share also grew, while free cash flow declined versus the prior-year quarter. For the first half of 2026, order intake rose 33% and net sales cli…